0001681871-17-000010.txt : 20170303
0001681871-17-000010.hdr.sgml : 20170303
20170303182731
ACCESSION NUMBER: 0001681871-17-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170106
FILED AS OF DATE: 20170303
DATE AS OF CHANGE: 20170303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eldessouky Sam
CENTRAL INDEX KEY: 0001558676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 17665867
MAIL ADDRESS:
STREET 1: 9 ROSZEL ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-01-06
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001558676
Eldessouky Sam
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
SVP, CHIEF ACCOUNTING OFFICER
Common Stock, no par value
2017-01-06
4
A
0
12799
0
A
66590
D
Restricted Share Units
2017-01-06
4
A
0
8534
0
A
2020-01-06
Common Stock
8534
8534
D
Non-Qualified Stock Options (right to purchase)
14.38
2017-03-01
4
A
0
31430
0
A
2027-03-01
Common Shares, no par value
31430
31430
D
Represents the award of restricted share units (RSUs) which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant").
Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 4,267 and the maximum number that can be distributed is 8,534. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's total shareholder return (TSR) as measured on January 6, 2020 (the Measurement Date). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award.
The options vest in equal installments on each of the first three anniversaries of the date of grant.
Kelly Webber POA for Osama A. Eldessouky
2017-03-03